Rueb Stoller Daniel is a nationally recognized mass tort and class action law firm dedicated to representing individuals harmed by defective products, dangerous drugs, and corporate negligence. With a strong presence across multiple states and a reputation for securing substantial settlements, the firm stands out for its leadership roles in plaintiff steering committees and its commitment to achieving justice for large groups of injured people.
The firm’s approach combines over fifty years of combined legal experience, technical knowledge of complex litigation, and a client-focused philosophy that includes 24/7 availability and contingency-based fees. They represent individuals and groups affected by widespread corporate misconduct, particularly in cases involving pharmaceuticals, medical devices, consumer products, and environmental disasters. Their attorneys are known for aggressively litigating against large corporations to maximize client compensation.
Services Offered
- Mass tort litigation
- Class action lawsuits
- Personal injury representation
- Pharmaceutical claims (e.g., Oxbryta, Depo-Provera, Valsartan)
- Medical device lawsuits (e.g., hip replacement, transvaginal mesh, IVC filter)
- Product liability claims (e.g., Fisher-Price baby sleeper, button battery ingestion)
- Environmental disaster litigation (e.g., wildfires, chemical exposure)
- Toxic tort cases (e.g., Roundup, Paraquat, talcum powder)
- Sexual abuse lawsuits
- Consumer protection litigation
- AFFF (aqueous film-forming foam) lawsuits
- Hair straightener chemical exposure cases
- NEC infant formula claims
- Medtronic Heartware HVAD litigation
- Roblox child exploitation lawsuits
- Paragard IUD cases
The firm serves clients nationwide with offices in Atlanta, Boston, Los Angeles, Phoenix, Washington D.C., San Francisco, and San Diego. Their attorneys hold leadership positions in multiple plaintiff steering committees and have achieved notable settlements, including a $510 million mass tort settlement and a $225 million mass tort resolution.
